{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:50Z","timestamp":1788509630657,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104334","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:40:42Z","timestamp":1779028842000},"page":"104334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Automation and digitalization in drug product process development"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6600-8872","authenticated-orcid":false,"given":"Sadegh","family":"Poozesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Frederick","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-5796","authenticated-orcid":false,"given":"Marc","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0606-0563","authenticated-orcid":false,"given":"Douglas","family":"Kiehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Pouryahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5747-7366","authenticated-orcid":false,"given":"Michael","family":"Lovette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104334_bib0001","unstructured":"FDA. FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs. (2025) Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs."},{"key":"10.1016\/j.xphs.2026.104334_bib0002","series-title":"General Principles For Model-Informed Drug Development M15","year":"2026"},{"key":"10.1016\/j.xphs.2026.104334_bib0003","unstructured":"FDA. Roadmap to reducing animal testing in preclinical safety studies. Available at: https:\/\/www.fda.gov\/files\/newsroom\/published\/roadmap_to_reducing_animal_testing_in_preclinical_safety_studies.pdf?utm_source=chatgpt.com."},{"key":"10.1016\/j.xphs.2026.104334_bib0004","series-title":"Preliminary QIG Considerations Regarding Pharmaceutical Process Models","author":"Agency","year":"2024"},{"key":"10.1016\/j.xphs.2026.104334_bib0005","doi-asserted-by":"crossref","DOI":"10.2174\/0113892010396035250710120501","article-title":"Towards pharmaceutical Industry 5.0: impact of artificial intelligence in drug discovery and development","volume":"27","author":"Jayakrishnan","year":"2025","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.xphs.2026.104334_bib0006","series-title":"The 17th International Business Conference for","article-title":"Emerging technologies in the pharmaceutical supply chains: a systematic review of Industry 5.0 challenges","author":"Takawira","year":"2024"},{"key":"10.1016\/j.xphs.2026.104334_bib0007","unstructured":"FDA. Guidance for industry, PAT-A framework for innovative pharmaceutical development, manufacturing and quality assurance. (2004) Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance."},{"key":"10.1016\/j.xphs.2026.104334_bib0008","volume":"8","year":"2011"},{"key":"10.1016\/j.xphs.2026.104334_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-71204-6","article-title":"Accelerated drug development using a digital formulator and a self-driving tableting data factory","author":"Abbas","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2026.104334_bib0011","doi-asserted-by":"crossref","DOI":"10.1039\/D6DD00024J","article-title":"Self-driving laboratories in Korea: a new era of autonomous discovery","author":"Hwang","year":"2026","journal-title":"Digit Discov"},{"issue":"1","key":"10.1016\/j.xphs.2026.104334_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41120-023-00077-6","article-title":"Structured content and data management\u2014enhancing acceleration in drug development through efficiency in data exchange","volume":"9","author":"Beierle","year":"2023","journal-title":"AAPS Open"},{"issue":"5","key":"10.1016\/j.xphs.2026.104334_bib0013","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.xphs.2021.09.046","article-title":"The future of CMC regulatory submissions: streamlining activities using structured content and data management","volume":"111","author":"Ahluwalia","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104334_bib0014","first-page":"25","article-title":"Digitalization: the route to biopharma 4.0","volume":"36","author":"Rathore","year":"2023","journal-title":"Biopharm Int"},{"key":"10.1016\/j.xphs.2026.104334_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125789","article-title":"Artificial intelligence revolution in drug discovery: a paradigm shift in pharmaceutical innovation","volume":"680","author":"Jarallah","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104334_bib0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-443-15688-5.00049-8","article-title":"Artificial intelligence drives the digital transformation of pharma","author":"Harrer","year":"2024","journal-title":"Artif Intell Clin Pract"},{"key":"10.1016\/j.xphs.2026.104334_bib0019","article-title":"Ensuring data integrity: best practices and strategies in pharmaceutical industry","author":"Gokulakrishnan","year":"2024","journal-title":"Intel Pharmacy"},{"key":"10.1016\/j.xphs.2026.104334_bib0020","series-title":"Part 11, Electronic Records; Electronic Signatures Scope and Application","author":"CFR","year":"2003"},{"issue":"3","key":"10.1016\/j.xphs.2026.104334_bib0021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s43393-021-00024-0","article-title":"Digital twin in biomanufacturing: challenges and opportunities towards its implementation","volume":"1","author":"Udugama","year":"2021","journal-title":"Syst Microbiol Biomanuf"},{"key":"10.1016\/j.xphs.2026.104334_bib0022","series-title":"Bioconvergence Revolution: Challenges and Opportunities in Research Productivity","first-page":"59","article-title":"Digital twins in biomanufacturing","author":"Canzoneri","year":"2024"},{"issue":"11","key":"10.1016\/j.xphs.2026.104334_bib0023","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ifacol.2018.08.474","article-title":"Digital Twin in manufacturing: a categorical literature review and classification","volume":"51","author":"Kritzinger","year":"2018","journal-title":"Ifac-PapersOnline"},{"issue":"9","key":"10.1016\/j.xphs.2026.104334_bib0024","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/pr8091088","article-title":"Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review","volume":"8","author":"Chen","year":"2020","journal-title":"Processes"},{"key":"10.1016\/j.xphs.2026.104334_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbiotec.2025.06.012","article-title":"Integrative in-silico models for mammalian cell cultures in single-use bioreactors: bridging hydrodynamics, kinetics, and process control across scales","volume":"406","author":"Dasgupta","year":"2025","journal-title":"J Biotechnol"},{"key":"10.1016\/j.xphs.2026.104334_bib0026","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jbiotec.2024.04.013","article-title":"An in-silico analysis of hydrodynamics and gas mass transfer characteristics in scale-down models for mammalian cell cultures","volume":"388","author":"Anand","year":"2024","journal-title":"J Biotechnol"},{"key":"10.1016\/j.xphs.2026.104334_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2024.109337","article-title":"Study of hydrodynamic stress in cell culture bioreactors via lattice-Boltzmann CFD simulations supported by micro-probe shear stress method","volume":"208","author":"\u0160rom","year":"2024","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.xphs.2026.104334_bib0028","series-title":"The IAVSD International Symposium on Dynamics of Vehicles on Roads and Tracks","first-page":"606","article-title":"Hybrid modelling in terramechanics","author":"Karpman","year":"2023"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104334_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2018.03.027","article-title":"Control of three different continuous pharmaceutical manufacturing processes: use of soft sensors","volume":"543","author":"Rehrl","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104334_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.coche.2024.101038","article-title":"The future of digital applications in pharmaceutical operations","volume":"45","author":"Pantelides","year":"2024","journal-title":"Curr Opin Chem Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122336","article-title":"Digital twin of a continuous direct compression line for drug product and process design using a hybrid flowsheet modelling approach","volume":"628","author":"Moreno-Benito","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104334_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2024.108899","article-title":"Physics-informed neural networks for dynamic process operations with limited physical knowledge and data","volume":"192","author":"Velioglu","year":"2025","journal-title":"Comput Chem Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2023.108195","article-title":"Physics-informed recurrent neural networks and hyper-parameter optimization for dynamic process systems","volume":"173","author":"Asrav","year":"2023","journal-title":"Comput Chem Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0034","unstructured":"Hu, Y., Anderson, L., Li, T.M., Sun, Q., Carr, N., Ragan-Kelley, J. and Durand, F., 2019. Difftaichi: Differentiable programming for physical simulation. arXiv preprint arXiv:1910.00935."},{"key":"10.1016\/j.xphs.2026.104334_bib0035","first-page":"6111","article-title":"Solver-in-the-loop: learning from differentiable physics to interact with iterative PDE-solvers","volume":"33","author":"Um","year":"2020","journal-title":"Adv Neural Inf Process Syst"},{"key":"10.1016\/j.xphs.2026.104334_bib0036","series-title":"Diff-Flowfsi: A Gpu-Optimized Differentiable Cfd Platform for High-Fidelity Turbulence and FSI Simulations","author":"Fan","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0037","series-title":"Forty-First International Conference on Machine Learning","article-title":"A decoder-only foundation model for time-series forecasting","author":"Das","year":"2024"},{"key":"10.1016\/j.xphs.2026.104334_bib0038","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fgene.2019.00524","article-title":"Review of causal discovery methods based on graphical models","volume":"10","author":"Glymour","year":"2019","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.xphs.2026.104334_bib0039","doi-asserted-by":"crossref","first-page":"86","DOI":"10.32996\/jcsts.2025.7.2.7","article-title":"Leveraging hybrid edge-cloud predictive maintenance in pharmaceutical MES: an Industry 4.0 approach using big data","volume":"7","author":"Parapalli","year":"2025","journal-title":"J Comput Sci Technol Stud"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104334_bib0040","first-page":"1","article-title":"Advances and open problems in federated learning","volume":"14","author":"Kairouz","year":"2021","journal-title":"Found Trends\u00ae Mach Learn"},{"issue":"6","key":"10.1016\/j.xphs.2026.104334_bib0041","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.xphs.2023.01.015","article-title":"Desferrioxamine enhances 5-aminolaevulinic acid-induced protoporphyrin ix accumulation and therapeutic efficacy for hypertrophic scar","volume":"112","author":"Chen","year":"2023","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104334_bib0042","doi-asserted-by":"crossref","DOI":"10.1088\/2632-2153\/adb0a0","article-title":"A graph neural network simulation of dispersed systems","volume":"6","author":"Hashemi","year":"2025","journal-title":"Mach Learn Sci Technol"},{"key":"10.1016\/j.xphs.2026.104334_bib0043","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.69997\/sct.101576","article-title":"Physics-informed graph neural networks for modeling spatially distributed dynamically operated processes","author":"Khalid","year":"2025","journal-title":"Syst Control Trans"},{"key":"10.1016\/j.xphs.2026.104334_bib0010","article-title":"Cyber-physical systems for digital medicines manufacturing: a self-optimising tableting DataFactory","volume":"35","author":"Salehian","year":"2025","journal-title":"ESCAPE"},{"key":"10.1016\/j.xphs.2026.104334_bib0044","unstructured":"FDA. Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products. (2025) Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological."},{"key":"10.1016\/j.xphs.2026.104334_bib0045","series-title":"Reflection Paper on the Use of Artificial Intelligence (AI) in the Medicinal Product Lifecycle","author":"Agency","year":"2023"},{"key":"10.1016\/j.xphs.2026.104334_bib0046","series-title":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use","article-title":"Analytical procedure development Q14","author":"Guideline","year":"2022"},{"key":"10.1016\/j.xphs.2026.104334_bib0047","series-title":"Q14 Analytical Procedure Development Guidance for Industry","year":"2024"},{"key":"10.1016\/j.xphs.2026.104334_bib0048","series-title":"Assessing Credibility of Computational Modeling Through Verification and Validation: Application to Medical Devices","year":"2018"},{"issue":"4","key":"10.1016\/j.xphs.2026.104334_bib0068","first-page":"58","article-title":"ChatGPT, BARD, and other large language models meet regulated pharma","volume":"43","author":"Blumenthal","year":"2023","journal-title":"Pharm Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0069","unstructured":"Agarwal, B., Jomraj, H.S., Kaplunov, S., Krolick, J. and Rojkova, V., 2025. Ragulating compliance: A multi-agent knowledge graph for regulatory qa. arXiv preprint arXiv:2508.09893."},{"key":"10.1016\/j.xphs.2026.104334_bib0070","unstructured":"FDA. (2025) FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-launches-agency-wide-ai-tool-optimize-performance-american-people."},{"issue":"1","key":"10.1016\/j.xphs.2026.104334_bib0071","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41746-025-01447-y","article-title":"Survey and perspective on verification, validation, and uncertainty quantification of digital twins for precision medicine","volume":"8","author":"Sel","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"1","key":"10.1016\/j.xphs.2026.104334_bib0072","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41746-025-01910-w","article-title":"A scoping review of human digital twins in healthcare applications and usage patterns","volume":"8","author":"Tudor","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.xphs.2026.104334_bib0049","first-page":"24","year":"2022","journal-title":"VVUQ 1 - Verification, Validation, and Uncertainty Quantification Terminology in Computational Modeling and Simulation"},{"key":"10.1016\/j.xphs.2026.104334_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2023.1157889","article-title":"Hybrid modeling for biopharmaceutical processes: advantages, opportunities, and implementation","volume":"5","author":"Narayanan","year":"2023","journal-title":"Front Chem Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0051","doi-asserted-by":"crossref","unstructured":"Shahab, M.A., Destro, F. and Braatz, R.D., 2025. Digital Twins in Biopharmaceutical Manufacturing: Review and Perspective on Human-Machine Collaborative Intelligence. arXiv preprint arXiv:2504.00286.","DOI":"10.1016\/j.eng.2026.07.039"},{"key":"10.1016\/j.xphs.2026.104334_bib0052","unstructured":"FDA. CDER\u2019s framework for regulatory advanced manufacturing evaluation (FRAME) initiative. (2026) Available at: https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/cders-framework-regulatory-advanced-manufacturing-evaluation-frame-initiative."},{"key":"10.1016\/j.xphs.2026.104334_bib0053","series-title":"AIAA Aviation Forum And Ascend 2025","first-page":"3107","article-title":"Challenge problem overview for the certification by analysis uncertainty quantification discussion group","author":"Bekemeyer","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2023.1076509","article-title":"CFD supported scale up of perfusion bioreactors in biopharma","volume":"5","author":"Kuschel","year":"2023","journal-title":"Front Chem Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0055","series-title":"Using CFD Multiphase Modeling to Predict Bioreactor Performance| Pharmaceutical Engineering","author":"Prado","year":"2020"},{"key":"10.1016\/j.xphs.2026.104334_bib0056","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymeth.2024.03.003","article-title":"Establishing finite element model credibility of a pedicle screw system under compression-bending: an end-to-end example of the ASME V&V 40 standard","volume":"225","author":"Nagaraja","year":"2024","journal-title":"Methods"},{"key":"10.1016\/j.xphs.2026.104334_bib0057","series-title":"VVUQ 40.1 - An Example of Assessing Computational Model Credibility using the ASME V&V 40 Risk-Based Framework: Tibial Tray Component Worst-Case Size Identification for Fatigue Testing","first-page":"73","year":"2026"},{"issue":"2","key":"10.1016\/j.xphs.2026.104334_bib0058","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.xphs.2024.11.021","article-title":"Qualification of mechanistic models in biopharmaceutical process development","volume":"114","author":"Briskot","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104334_bib0059","first-page":"1","article-title":"Standard for verification and validation in computational fluid dynamics and heat transfer: ASME V&V 20","volume":"2009","author":"Coleman","year":"2009","journal-title":"Am Soc Mech Eng"},{"key":"10.1016\/j.xphs.2026.104334_bib0060","series-title":"Verification, Validation, and Uncertainty Quantification in Scientific Computing","author":"Oberkampf","year":"2025"},{"issue":"3","key":"10.1016\/j.xphs.2026.104334_bib0061","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1208\/s12249-021-01960-9","article-title":"Analytical method lifecycle management in pharmaceutical industry: a review","volume":"22","author":"Volta e Sousa","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2026.104334_bib0062","first-page":"376","article-title":"Applying machine learning to the visual inspection of filled injectable drug products","volume":"77","author":"Veillon","year":"2023","journal-title":"PDA J Pharm Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104334_bib0063","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12247-026-10565-3","article-title":"Application of machine learning in predicting critical granule quality attributes for modeling of relationship between the properties of natural medicine and process attributes","volume":"21","author":"Dongli","year":"2026","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.xphs.2026.104334_bib0064","author":"US Food and Drug Administration"},{"key":"10.1016\/j.xphs.2026.104334_bib0065","series-title":"FDA, CTTI Convening 2025 Hybrid Public Workshop on Artificial Intelligence in Drug & Biological Product Development","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0066","first-page":"1","article-title":"Fair human-centric image dataset for ethical AI benchmarking","author":"Xiang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2026.104334_bib0067","series-title":"Artificial Intelligence and DEI","year":"2024"},{"issue":"4","key":"10.1016\/j.xphs.2026.104334_bib0073","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.xphs.2020.01.020","article-title":"Transitioning chemistry, manufacturing, and controls content with a structured data management solution: streamlining regulatory submissions","volume":"109","author":"Algorri","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104334_bib0074","article-title":"FDA\u2019s new pharmaceutical quality initiative: knowledge-aided assessment & structured applications","volume":"1","author":"Lawrence","year":"2019","journal-title":"Int J Pharm X"},{"issue":"6","key":"10.1016\/j.xphs.2026.104334_bib0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/d41573-019-00193-7","article-title":"Cloud-based data systems in drug regulation: an industry perspective","volume":"19","author":"Robertson","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.xphs.2026.104334_bib0076","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.xphs.2019.02.007","article-title":"Innovation in chemistry, manufacturing, and controls\u2014a regulatory perspective from industry","volume":"108","author":"Cauchon","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104334_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120554","article-title":"Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future","volume":"602","author":"Arden","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104334_bib0078","unstructured":"FDA. FDA\u2019s Technology Modernization Action Plan (TMAP). (2019) Available at: https:\/\/www.fda.gov\/media\/130883\/download?attachment."},{"key":"10.1016\/j.xphs.2026.104334_bib0079","unstructured":"FDA. Data Modernization Action Plan (DMAP). (2021) Available at: https:\/\/www.fda.gov\/media\/143627\/download?attachment."},{"key":"10.1016\/j.xphs.2026.104334_bib0080","series-title":"Accumulus Synergy Powers Industry\u2019s First Digitally Generated Dossier to Nearly Two Dozen","author":"Synergy","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0081","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12027-023-00732-1","article-title":"The European Health Union and the protection of public health in the European Union: is the European Union prepared for future cross-border health threats?","volume":"23","author":"Seitz","year":"2023","journal-title":"ERA Forum"},{"key":"10.1016\/j.xphs.2026.104334_bib0082","series-title":"Proceedings of the 40th ACM\/SIGAPP Symposium on Applied Computing","first-page":"1293","article-title":"From rag to QA-RAG: integrating generative ai for pharmaceutical regulatory compliance process","author":"Kim","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0083","unstructured":"J.S. Rayo Mosquera, C.R. De La Rosa Peredo, M. Garrido, A hybrid approach to information retrieval and answer generation for regulatory texts, in: Proc. 1st Regul. NLP Workshop (RegNLP 2025), ACL, Abu Dhabi, UAE, 2025, pp. 31\u201335."},{"key":"10.1016\/j.xphs.2026.104334_bib0084","unstructured":"Gaertner R. Quality Zone Highlights: AI Comes to Veeva Quality Cloud, Enhanced Industry Collaboration, Plus Other Advances. (2025) https:\/\/www.veeva.com\/eu\/blog\/quality-zone-highlights-ai-comes-to-veeva-quality-cloud-enhanced-industry-collaboration-plus-other-advances\/"},{"key":"10.1016\/j.xphs.2026.104334_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125625","article-title":"Quality by digital design to accelerate sustainable medicines development","volume":"681","author":"Mustoe","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104334_bib0086","article-title":"Artificial intelligence for drug delivery: yesterday, today and tomorrow","author":"Wu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2026.104334_bib0087","volume":"1","author":"Guideline","year":"2022"},{"key":"10.1016\/j.xphs.2026.104334_bib0088","unstructured":"EFPIA, EFPIA position on the use of artificial intelligence in the medicinal product lifecycle, European Federation of Pharmaceutical Industries and Associations, October 2024. Available at: https:\/\/www.efpia.eu\/media\/tzeavw1t\/efpia-position-on-the-use-of-artificial-intelligence-in-the-medicinal-product-lifecycle.pdf (Accessed May 28, 2026)."},{"issue":"6","key":"10.1016\/j.xphs.2026.104334_bib0089","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/ph18060901","article-title":"Regulatory perspectives for AI\/ML implementation in pharmaceutical GMP environments","volume":"18","author":"Niazi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.xphs.2026.104334_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4196\/kjpp.2024.28.5.393","article-title":"The transformative impact of large language models on medical writing and publishing: current applications, challenges and future directions","volume":"28","author":"Ahn","year":"2024","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.xphs.2026.104334_bib0091","series-title":"AI-Driven Digital Validation: Transforming Compliance and Quality in Pharmaceutical Manufacturing","author":"Amin","year":"2025"},{"key":"10.1016\/j.xphs.2026.104334_bib0092","series-title":"Generative AI in the Pharmaceutical Industry: Moving from Hype to Reality","author":"Viswa","year":"2024"},{"issue":"6","key":"10.1016\/j.xphs.2026.104334_bib0093","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/bioengineering12060631","article-title":"Large language models in healthcare and medical applications: a review","volume":"12","author":"Maity","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.xphs.2026.104334_bib0094","unstructured":"ISPE, New GAMP\u00ae Guide Addresses Challenges Posed by AI-Enabled Computerized Systems, International Society for Pharmaceutical Engineering, 24 July 2025. Available at: https:\/\/ispe.org\/pharmaceutical-engineering\/ispeak\/new-gampr-guide-addresses-challenges-posed-ai-enabled (Accessed May 28, 2026)."},{"key":"10.1016\/j.xphs.2026.104334_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2026.107449","article-title":"Empowering the pharmaceutical workforce for the digital future","volume":"220","author":"Maclean","year":"2026","journal-title":"Eur J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:34:28Z","timestamp":1788507268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926001838"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104334","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automation and digitalization in drug product process development","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104334"}}